The Clinical Influence of Developing a Sustainable Cardiac Surgery Service to Reduce the Burden of Rheumatic Heart Disease in Sub-Saharan Africa

Recruiting Observational Study
Rheumatic Heart Disease Anticoagulant Adverse Reaction
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
14 and older
Sex
Any
Study type
Observational
Participants needed
200 (estimated)
Sponsor
Helse Nord-Trøndelag HF · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
In this bi-directional program of education, training and research activities based on sustainable development goals aim is to develop cardiac surgery service in Ethiopia. The aim is to evaluate the short and long-term outcome of cardiac surgery for rheumatic heart disease in a low-income country compared to individuals not offered cardiac surgery due to limited availability of the service. Secon…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Cardiac surgery due to rheumatic heart disease at the governmental Black Lion University Hospital during the bi-directional programme of education, training and Research to establish Cardiac surgery service Exclusion Criteria: * Not willing or able to provide written informe…
Contacts

Haavard Dalen, MD, PhD

74098206

havard.dalen@ntnu.no

CONTACT

Rune Haaverstad, MD, PhD

55 97 22 20

rune.haaverstad@helse-bergen.no

CONTACT